← All organizations

Highest phase reached
Phase 4
First clinical trial
Apr 1, 2010Last known activity
Sep 1, 2024
Timeline
1990s
- Jan 1, 1999
South London and Maudsley NHS Foundation Trust— Founded
Drugs by trial phase (21 distinct, 11 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT06537921CollaboratorN/ASep 1, 2024
- NCT06270108CollaboratorEarly Phase 1Nov 14, 2022
- NCT05870501CollaboratorN/AOct 20, 2021
- NCT04959253CollaboratorPhase 2Sep 1, 2020
- NCT05164549CollaboratorPhase 3Aug 6, 2019
- NCT05164549Overall official - principal investigatorPhase 3Aug 6, 2019
- NCT03093064CollaboratorPhase 1Apr 1, 2017
- NCT03004521CollaboratorPhase 4Dec 1, 2016
- NCT02906553CollaboratorN/ASep 1, 2016
- NCT02249299CollaboratorN/AAug 1, 2014
- NCT02928965CollaboratorPhase 2Feb 1, 2013
- NCT00973908CollaboratorPhase 2/Phase 3Apr 1, 2010
Details
- Founded
- London, GB Jan 1, 1999
- Last known activity
- Sep 1, 2024